EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.45
(-0.68%)
AUD 1.45
(-0.68%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.14 Million | 4.01 Million | 1.9 Million | 253.53 Thousand | 2.97 Million | 416.32 Thousand |
| Net Income | 6.96 Million | 3.62 Million | 1.31 Million | 2.03 Million | 1.58 Million | 823.81 Thousand |
| Depreciation & Amortization | 391.53 Thousand | 182.04 Thousand | 118.34 Thousand | 125.51 Thousand | 146.51 Thousand | 3404.00 |
| Deferred income taxes | - | -383.96 Thousand | 239.94 Thousand | - | - | - |
| Stock-based compensation | - | 175.88 Thousand | 156.27 Thousand | - | - | - |
| Change in working capital | -1.15 Million | 241.75 Thousand | 314.69 Thousand | -1.9 Million | 1.24 Million | -410.88 Thousand |
| Other non-cash items | 1.97 Million | 168.81 Thousand | -239.94 Thousand | 1495.00 | -767.73 Thousand | 775.09 Thousand |
| Investing Cash Flow | -441.17 Thousand | -101.78 Thousand | -13.17 Thousand | -16.11 Thousand | -91.19 Thousand | -2543.00 |
| Investments in PPE | -409.28 Thousand | -101.78 Thousand | -13.17 Thousand | -16.11 Thousand | -91.19 Thousand | -2543.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -31.88 Thousand | - | -7500.00 | -10.15 Thousand | -1198.00 | - |
| Financing Cash Flow | -582.45 Thousand | -761.71 Thousand | -277.35 Thousand | 5.44 Million | -122.24 Thousand | - |
| Debt repayment | - | -161.32 Thousand | -104.19 Thousand | -107.26 Thousand | -122.24 Thousand | - |
| Dividends payments | -1.08 Million | -600.39 Thousand | -173.16 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | -449.83 Thousand | - | - |
| Common Stock Issuance | 854.1 Thousand | - | - | 6 Million | - | - |
| Other Financing Activities | -354.73 Thousand | -161.32 Thousand | -104.19 Thousand | 107.26 Thousand | -122.24 Thousand | - |
| Accounts receivables | -1.28 Million | 906.17 Thousand | -105.02 Thousand | 346.08 Thousand | -464.97 Thousand | -2.41 Million |
| Accounts payables | 593.22 Thousand | -215.64 Thousand | 778.71 Thousand | -1.56 Million | 1.55 Million | 1.64 Million |
| Inventory | -554.27 Thousand | -534.51 Thousand | -40.78 Thousand | -238.8 Thousand | -32.81 Thousand | - |
| Other working capital | 91.15 Thousand | 85.75 Thousand | -318.2 Thousand | -448.86 Thousand | 180.97 Thousand | 357.39 Thousand |
| Cash at beginning of period | 13.83 Million | 10.46 Million | 8.85 Million | 3.17 Million | 413.88 Thousand | 100.00 |
| Cash at end of period | 19.02 Million | 13.83 Million | 10.46 Million | 8.85 Million | 3.17 Million | 413.88 Thousand |
| Capital Expenditure | -409.28 Thousand | -101.78 Thousand | -13.17 Thousand | -16.11 Thousand | -91.19 Thousand | -2543.00 |
| Effect of forex changes on cash | 71.63 Thousand | 215.15 Thousand | - | -1494.00 | - | - |
| Net cash flow / Change in cash | 5.19 Million | 3.36 Million | 1.61 Million | 5.67 Million | 2.76 Million | 413.78 Thousand |
| Free Cash Flow | 5.73 Million | 3.91 Million | 1.88 Million | 237.41 Thousand | 2.88 Million | 413.78 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.82 Million | 6.96 Million | 1.14 Million | 571.18 Thousand | 3.62 Million | 2.33 Million |
| Depreciation & Amortization | 200.23 Thousand | 391.53 Thousand | 191.3 Thousand | 95.65 Thousand | 182.04 Thousand | 123.84 Thousand |
| Deferred income taxes | - | - | -793.34 Thousand | - | -383.96 Thousand | 1.68 Million |
| Stock-based compensation | - | - | 144.00 | 144.00 | 175.88 Thousand | 20.83 Thousand |
| Change in working capital | 511.45 Thousand | -1.15 Million | -1.66 Million | -1.87 Million | 241.75 Thousand | 2.37 Million |
| Other non-cash items | 1.18 Million | 1.97 Million | 793.48 Thousand | 1.03 Million | 168.81 Thousand | -1.88 Million |
| Investing Cash Flow | -160.89 Thousand | -441.17 Thousand | -280.27 Thousand | -140.13 Thousand | -101.78 Thousand | -99.82 Thousand |
| Investments in PPE | -372.29 Thousand | -441.17 Thousand | -68.87 Thousand | -140.13 Thousand | -101.78 Thousand | -99.82 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 179.51 Thousand | - | -211.4 Thousand | - | - | - |
| Financing Cash Flow | 16.26 Thousand | -582.45 Thousand | -598.71 Thousand | -299.35 Thousand | -761.71 Thousand | -526.04 Thousand |
| Debt repayment | - | - | - | - | -161.32 Thousand | - |
| Dividends payments | -657.37 Thousand | -1.08 Million | -424.44 Thousand | -212.22 Thousand | -600.39 Thousand | -416.22 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 854.1 Thousand | 854.1 Thousand | - | - | - | - |
| Other Financing Activities | -180.46 Thousand | - | -87.13 Thousand | -87.13 Thousand | -161.32 Thousand | -54.91 Thousand |
| Accounts receivables | 602.86 Thousand | -1.28 Million | -1.88 Million | -944.43 Thousand | 906.17 Thousand | 1.84 Million |
| Accounts payables | -1.59 Million | 593.22 Thousand | 2.19 Million | - | -215.64 Thousand | 230.42 Thousand |
| Inventory | 158.26 Thousand | -554.27 Thousand | -712.54 Thousand | -356.27 Thousand | -534.51 Thousand | -116.38 Thousand |
| Other working capital | 1.34 Million | 91.15 Thousand | -1.25 Million | -570.85 Thousand | 85.75 Thousand | 394.23 Thousand |
| Cash at beginning of period | 12.61 Million | 13.83 Million | 13.83 Million | - | 10.46 Million | 9.58 Million |
| Cash at end of period | 19.02 Million | 19.02 Million | 12.61 Million | -606.18 Thousand | 13.83 Million | 13.83 Million |
| Capital Expenditure | -372.29 Thousand | -441.17 Thousand | -68.87 Thousand | -140.13 Thousand | -101.78 Thousand | -99.82 Thousand |
| Effect of forex changes on cash | - | - | - | - | 215.15 Thousand | 107.57 Thousand |
| Net cash flow / Change in cash | 6.4 Million | 5.19 Million | -1.21 Million | -606.18 Thousand | 3.36 Million | 4.24 Million |
| Free Cash Flow | 6.1 Million | 5.7 Million | -402.26 Thousand | -306.83 Thousand | 3.91 Million | 4.55 Million |
GEL
0LC3
002419
GGL
300905
NBPS